Mounjaro Pen Change 2026​

A Mounjaro pen change is coming to the UK in 2026, and many patients may notice small differences when they receive their next prescription.

Mounjaro is a GLP-1 weight loss injection supplied in a multi-dose KwikPen device. Each pen delivers four weekly injections and is commonly prescribed as part of a structured Mounjaro weight loss programme.

From April 2026, updated versions of the Mounjaro KwikPen will begin appearing in the UK. The injection process remains the same, but the manufacturer has introduced a small design update to help reduce confusion about leftover liquid in the pen.

This article explains the Mounjaro pen change, what it means for patients, and what you may notice when using the updated device.

How Mounjaro Pens Currently Work

Each Mounjaro KwikPen contains four weekly doses of medication which are taken according to a structured Mounjaro dosage schedule.

The pen also contains a small amount of extra liquid for priming before each injection. Priming ensures the pen works correctly and allows the full dose to be delivered.

However, many patients noticed that some liquid appeared to remain inside the pen after the fourth injection. This sometimes caused confusion, as some people believed another full dose remained.

In reality, the pen had already delivered all four doses. In some situations, this misunderstanding caused patients to delay starting a new pen while waiting to use the remaining liquid.

To address this issue, the manufacturer has introduced a Mounjaro pen change designed to make the end of the pen clearer.

Is There a “5th Dose” or “Golden Dose” in a Mounjaro Pen?

Some patients refer to a so-called “5th dose” or “golden dose” when using a Mounjaro KwikPen.

This term comes from the small amount of liquid that may appear to remain in the pen after the fourth injection. Because the pen still contains visible medication, some people assume another full dose can be taken.

However, a Mounjaro KwikPen is designed to deliver four doses only.

The remaining liquid is included to allow for priming before each injection, which helps remove air from the needle and ensures the pen delivers the correct dose. This extra volume is not intended to provide an additional weekly dose.

Although patients sometimes discuss extracting or attempting to use this leftover liquid, doing so may lead to:

• An incorrect dose

• Damage to the pen device

• Inconsistent medication delivery

For these reasons, manufacturers and healthcare professionals advise that the pen should be discarded after the fourth injection, even if a small amount of liquid appears to remain.

What Is Changing With the Mounjaro Pen?

Eli Lilly and Company has confirmed that updated Mounjaro KwikPens will begin appearing in the UK from April 2026.

The updated device still works in the same way. The Mounjaro pen change only affects the internal design of the pen mechanism.

The new pens will still be:

• Single-patient use

• Disposable after use

• Multi-dose pens containing four weekly injections

However, the internal plunger mechanism has been adjusted so the pen moves further through the cartridge as each dose is delivered.

This design improvement helps reduce the amount of visible leftover liquid and makes it easier to see when the pen has reached its final dose.

Will the Injection Process Change?

No. The Mounjaro pen change does not affect how you use the injection.

Patients should continue using the pen exactly as before and follow the recommended instructions for how to use a Mounjaro pen safely.

The updated pen will still:

• Require priming before each injection

• Deliver four weekly doses

• Contain the correct volume of medicine for priming and injections

This means your weekly injection routine will stay the same.

Why the Mounjaro Pen Change Matters

The design update aims to make the device clearer and easier for patients to use.

The Mounjaro pen change helps to:

• Reduce confusion about leftover liquid in the pen

• Make it clearer when the pen is finished

• Prevent patients delaying their next dose

Many patients found it difficult to judge when their pen had fully emptied. The updated design helps provide a clearer visual indicator when the pen should be discarded.

What Patients Should Be Aware Of

Although the medication and injection process remain unchanged, the updated device may look slightly different.

From April 2026, pharmacies may supply both the original and updated pens for a short period while existing stock is used.

Because of this transition period, patients should always:

• Check the pen when they receive it

• Read the Patient Information Leaflet

• Follow the Instructions for Use provided with the device

If you are unsure about your pen or how to use it, you should speak to your pharmacist or prescriber.

Key Differences in the New Mounjaro Pens

You may notice several small visual differences with the updated pen.

Photo credit: Eli Lilly UK. 

1. Plunger Position

In the updated pen, the plunger inside the viewing window sits slightly lower in the cartridge before the pen is used.

This is normal and is part of the new design introduced as part of the Mounjaro pen change.

2. Extended Plunger Component

The updated pen contains a longer internal plunger component positioned behind the cartridge.

This extension allows the plunger to travel further through the pen as each weekly dose is delivered.

This design helps make the final position of the plunger clearer after the last injection.

3. Clearer End-of-Pen Indicator

After the fourth and final dose, the plunger will sit much closer to the end of the cartridge.

This makes it easier for patients to see that:

• All four doses have been delivered

• The pen should now be safely discarded

This clearer visual indicator is one of the main goals of the Mounjaro pen change.

How the New Mounjaro Pen Design Helps Reduce the Confusion

One reason for the upcoming Mounjaro pen change is to reduce misunderstanding about leftover liquid.

The updated pen design moves the plunger further through the cartridge after each injection. After the fourth dose, the plunger will sit much closer to the end of the pen.

This clearer visual indicator helps patients see that:

• The pen has delivered all four doses

• The device should now be discarded

By reducing visible leftover liquid, the updated design helps prevent confusion around the so-called “5th dose” or “golden dose.”

If you are exploring weight management treatments, you can also review other medically approved weight loss treatments and alternatives that may be suitable depending on your health needs.